APR 23, 2018 12:37 PM PDT

Damaged Heart Cells Can Regenerate Using Innovative Technique

WRITTEN BY: Kara Marker

There is no definitive “treatment” for the damage that results from a heart attack because the heart cells cannot regenerate themselves after such an attack. But scientists from Columbia University present a new approach that involves using heart cells’ own molecular messages to improve regeneration after a heart attack.

Immunofluorescent staining for F-actin filaments (green) and nuclei (blue) in neonatal cardiomyocytes. Credit: Ps1415

After the death of heart muscle cells, called cardiomyocytes, in the wake of a heart attack, the heart is unable to adequately pump blood. Essentially, the heart is forced to do the same job but with less cells.

The response by scientists from all over the world has recently been stem cell transplantation to replace dead and damaged cardiomyocytes with new cells to improve heart function after a heart attack. However, there are several problems associated with this approach. First, implanted stem cells don’t always survive or successfully transform into cardiomyocytes as intended. Additionally, implanted cardiomyocytes often fail to beat synchronously with the heart, increasing the risk of dangerous abnormal heart rhythms called arrhythmias.

The new approach designed by the team from Columbia University involves applying extracellular vesicles secreted by the cardiomyocytes themselves. These vesicles are secreted by virtually all cell types, and cells use the genetic information the vesicles contain to communicate with other cells.

“We postulated that the benefits of cell therapy of the heart could be coming from the secreted bioactive molecules (such as microRNAs), rather than the cells themselves," explained senior author Vunjak-Novakovic. "So we explored whether the benefits of cell therapy of the injured heart could be achieved without using the cells. This way, we would largely simplify the translation into the clinic, and avoid the burden of arrhythmia associated with implantation of contractile cells."

Developing a therapeutic approach to heart attack using these vesicles has several advantages over a more traditional cell-based therapy. First, the vesicles are easily to isolate and store, so they can either be used immediately in an “acute-care setting” or be saved for later use. As opposed to implanted stem cells, extracellular vesicles do not raise the risk of arrhythmia, and their regulatory path towards clinical application is simpler than the path for cell-based therapies.

Researchers evaluated the effectiveness of this approach first by isolated cardiomyocytes from adult human stem cells and collected their secreted extracellular vesicles. Next, they used next-generation sequencing to compare the genetic information in these vesicles compared to vesicles secreted by undifferentiated stem cells.

They found that extracellular vesicles from cardiomyocytes, not from undifferentiated stem cells, contained powerful regulatory molecules called “cardiogenic and vasculogenic microRNAs.”

Next researchers developed a collagen-based patch that takes the vesicles and releases them slowly over four weeks. They implanted the patch into the hearts of rats used as a model of heart attack. Researchers found that the rate of arrhythmia was much lower in this scenario than with cell therapy.

“By four weeks after treatment, the hearts treated with extracellular vesicles had similar cardiac function as those that were never injured,” Vunjak-Novakovic said.

"Once we better understand how exactly the extracellular vesicles do what they do," Vunjak-Novakovic concluded, "we should be able to extend their use to a range of cardiovascular diseases, and significantly advance the field of cell-free heart therapy."

The present study was published in the journal Nature Biomedical Engineering.

Source: Columbia University School of Engineering and Applied Science

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 23, 2019
Cardiology
JUL 23, 2019
Paleo Diet Alters Microbiome, May Harm Heart
New findings have raised concerns over the Paleolithic or Paleo diet. Recent research into the diet suggests that it lacks key nutritional components relat...
AUG 01, 2019
Cardiology
AUG 01, 2019
Preventing Sarcopenia In Older Adults
The loss of muscle mass associated with aging, called sarcopenia, begins at about age 30 and continues throughout an individual's lifespan. This muscle...
AUG 08, 2019
Cardiology
AUG 08, 2019
The Best Way to Test Blood Pressure and Find Heart Disease
Heart disease causes hundreds of thousands of deaths annually -- can a new study on blood pressure tests guide doctors toward earlier diagnosis? About one ...
SEP 18, 2019
Cardiology
SEP 18, 2019
Clear, Flexible Vital Sign Wearable Monitors
Wearable health monitors are gaining in popularity, both for fitness tracking and for gathering more targeted health data relating to heart disease and oth...
JAN 03, 2020
Cardiology
JAN 03, 2020
Healthy Sleep May Offset Genetic Heart Disease Risk
People with a high genetic risk of heart disease or stroke may be able to offset that risk with healthy sleep patterns, according to new research. The rese...
JAN 09, 2020
Neuroscience
JAN 09, 2020
Increased Autism Risk for Children Born with Heart Disease
Children born with congenital heart disease (CHD) have a life expectancy comparable to that of the general population. However, despite advances in medical...
Loading Comments...